FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054069920> ?p ?o ?g. }

• W2054069920 endingPage "1756" @default.
• W2054069920 startingPage "1749" @default.
• W2054069920 abstract "Objective We compared a case-series of ten patients who developed prolonged neuromuscular weakness after continuous, nondepolarizing, neuromuscular blockade with a group of controls without neuromuscular weakness to determine the economic impact of the neuromuscular weakness. Design Frequency-matched case control trial. Setting Medical and surgical intensive care units of a 937-bed tertiary care, university-affiliated teaching hospital. Patients Ten patients developed prolonged neuromuscular weakness after continuous administration of nondepolarizing neuromuscular blockers. Ten patients from a 1994 drug utilization database who did not develop motor weakness after paralysis were identified to serve as controls. Measurements and Main Results The medical and accounting records of the patients were retrospectively reviewed. Charge data were obtained from patient accounts. Institutional ratios to convert charges to full costs and marginal costs were obtained from the Hospital Finance Department of Henry Ford Hospital. The economic impact of the diagnosis and recovery of the motor weakness was estimated for the intensive care unit (ICU) and hospital stays and compared with those values for control patients. Median hospital charges (excluding rehabilitation), totaling $91,476, were attributed to the patients who developed neuromuscular weakness and included charges for neuromuscular blocking agents, continuous mechanical ventilation, ICU and hospital beds, neurologic studies, and physical therapy services. In the control patients, median charges were $22,191 (p = .001). The total median cost differential for a patient in the neuromuscular weakness group was in excess of $66,713 (95% confidence interval $23,485 to $189,214, p = .001). Significant differences were also found for patient charges, full costs, and marginal costs for mechanical ventilation (p = .002), neurologic studies (p = .014), as well as ICU (p = .002) and hospital (p = .001) stays. Conclusions The development of motor weakness was associated with an increase in ICU and hospital stays, continued mechanical ventilation, and disproportionate healthcare expenditures in excess of $66,000 per patient. A prospective evaluation of the true prevalence of neuromuscular weakness after neuromuscular blockade and of the costs to the healthcare system is needed. (Crit Care Med 1996; 24:1749-1756)" @default.
• W2054069920 created "2016-06-24" @default.
• W2054069920 creator A5004588910 @default.
• W2054069920 creator A5024748503 @default.
• W2054069920 creator A5041355170 @default.
• W2054069920 creator A5042250367 @default.
• W2054069920 creator A5059452920 @default.
• W2054069920 creator A5061439030 @default.
• W2054069920 creator A5084237031 @default.
• W2054069920 date "1996-10-01" @default.
• W2054069920 modified "2023-10-16" @default.
• W2054069920 title "Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit" @default.
• W2054069920 cites W1550111394 @default.
• W2054069920 cites W1852571976 @default.
• W2054069920 cites W1978970840 @default.
• W2054069920 cites W1979068045 @default.
• W2054069920 cites W1984032178 @default.
• W2054069920 cites W1993353641 @default.
• W2054069920 cites W1995632888 @default.
• W2054069920 cites W2013249087 @default.
• W2054069920 cites W2014163355 @default.
• W2054069920 cites W2025289732 @default.
• W2054069920 cites W2032246295 @default.
• W2054069920 cites W2045282512 @default.
• W2054069920 cites W2066242994 @default.
• W2054069920 cites W2075242275 @default.
• W2054069920 cites W2079268094 @default.
• W2054069920 cites W2094185278 @default.
• W2054069920 cites W2139900185 @default.
• W2054069920 cites W2155813406 @default.
• W2054069920 cites W2157675007 @default.
• W2054069920 cites W2170350031 @default.
• W2054069920 cites W2337599582 @default.
• W2054069920 cites W2405616158 @default.
• W2054069920 cites W2725188872 @default.
• W2054069920 doi "https://doi.org/10.1097/00003246-199610000-00024" @default.
• W2054069920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8874316" @default.
• W2054069920 hasPublicationYear "1996" @default.
• W2054069920 type Work @default.
• W2054069920 sameAs 2054069920 @default.
• W2054069920 citedByCount "87" @default.
• W2054069920 countsByYear W20540699202012 @default.
• W2054069920 countsByYear W20540699202013 @default.
• W2054069920 countsByYear W20540699202014 @default.
• W2054069920 countsByYear W20540699202015 @default.
• W2054069920 countsByYear W20540699202016 @default.
• W2054069920 countsByYear W20540699202017 @default.
• W2054069920 countsByYear W20540699202018 @default.
• W2054069920 countsByYear W20540699202019 @default.
• W2054069920 countsByYear W20540699202020 @default.
• W2054069920 countsByYear W20540699202021 @default.
• W2054069920 countsByYear W20540699202022 @default.
• W2054069920 crossrefType "journal-article" @default.
• W2054069920 hasAuthorship W2054069920A5004588910 @default.
• W2054069920 hasAuthorship W2054069920A5024748503 @default.
• W2054069920 hasAuthorship W2054069920A5041355170 @default.
• W2054069920 hasAuthorship W2054069920A5042250367 @default.
• W2054069920 hasAuthorship W2054069920A5059452920 @default.
• W2054069920 hasAuthorship W2054069920A5061439030 @default.
• W2054069920 hasAuthorship W2054069920A5084237031 @default.
• W2054069920 hasConcept C126322002 @default.
• W2054069920 hasConcept C141071460 @default.
• W2054069920 hasConcept C177713679 @default.
• W2054069920 hasConcept C1862650 @default.
• W2054069920 hasConcept C194828623 @default.
• W2054069920 hasConcept C195910791 @default.
• W2054069920 hasConcept C206044474 @default.
• W2054069920 hasConcept C2776356578 @default.
• W2054069920 hasConcept C2776376669 @default.
• W2054069920 hasConcept C2776418732 @default.
• W2054069920 hasConcept C2777080012 @default.
• W2054069920 hasConcept C2779134260 @default.
• W2054069920 hasConcept C2780247198 @default.
• W2054069920 hasConcept C2909465803 @default.
• W2054069920 hasConcept C2910841738 @default.
• W2054069920 hasConcept C2987404301 @default.
• W2054069920 hasConcept C42219234 @default.
• W2054069920 hasConcept C71924100 @default.
• W2054069920 hasConceptScore W2054069920C126322002 @default.
• W2054069920 hasConceptScore W2054069920C141071460 @default.
• W2054069920 hasConceptScore W2054069920C177713679 @default.
• W2054069920 hasConceptScore W2054069920C1862650 @default.
• W2054069920 hasConceptScore W2054069920C194828623 @default.
• W2054069920 hasConceptScore W2054069920C195910791 @default.
• W2054069920 hasConceptScore W2054069920C206044474 @default.
• W2054069920 hasConceptScore W2054069920C2776356578 @default.
• W2054069920 hasConceptScore W2054069920C2776376669 @default.
• W2054069920 hasConceptScore W2054069920C2776418732 @default.
• W2054069920 hasConceptScore W2054069920C2777080012 @default.
• W2054069920 hasConceptScore W2054069920C2779134260 @default.
• W2054069920 hasConceptScore W2054069920C2780247198 @default.
• W2054069920 hasConceptScore W2054069920C2909465803 @default.
• W2054069920 hasConceptScore W2054069920C2910841738 @default.
• W2054069920 hasConceptScore W2054069920C2987404301 @default.
• W2054069920 hasConceptScore W2054069920C42219234 @default.
• W2054069920 hasConceptScore W2054069920C71924100 @default.
• W2054069920 hasIssue "10" @default.
• W2054069920 hasLocation W20540699201 @default.

• next